{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:06:36Z","timestamp":1747181196599,"version":"3.40.5"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,2]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Deficiency of natural anticoagulant antithrombin was first reported as a genetic risk factor for venous thromboembolism, antithrombin III (AT III) is encoded by the serpin family C member 1 (<jats:italic toggle=\"yes\">SERPINC1<\/jats:italic>) gene, consisting of 432 amino acids, including 3 disulfide bonds and 4 possible glycosylation sites. Studies have shown that hereditary AT deficiency increases the incidence of venous thromboembolism by up to 20 times.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation:<\/jats:title>\n            <jats:p>The case presented a 27-year-old young man with no acquired risk factors and a sudden onset of right lower extremity venous thrombosis and pulmonary embolism. A heterozygous mutation in gene <jats:italic toggle=\"yes\">SERPINC1<\/jats:italic> of c.1154-14G&gt;A was detected in the patient, which is a deleterious mutation resulting in reduced AT III activity and increased risk of thrombotic events. The patient received anticoagulant therapy for approximately 5 months, and the thrombus gradually dissolved and no recurrent thrombotic events occurred during follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion:<\/jats:title>\n            <jats:p>AT deficiency is a rare autosomal dominant genetic disease, they are mainly divided into 2 types according to the different effects on the structure or function of the encoded protein. The patient had a mutation in the <jats:italic toggle=\"yes\">SERPINC1<\/jats:italic> gene (c.1154-14G&gt;A). Several cases of this type of mutation have been reported since 1991, and it is classified as AT deficiency type I.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Thrombosis in patients with antithrombin deficiency is often unpredictable and can lead to fatal pulmonary embolism. Early genetic testing for hereditary thrombophilia in venous thromboembolism patients without obvious high-risk factors is critical. Long-term anticoagulation treatment is an effective treatment, for this type of type I AT III deficiency combined with pulmonary embolism patients, warfarin is an effective anticoagulant drug.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000039175","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T17:19:07Z","timestamp":1722619147000},"page":"e39175","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Atypical pulmonary thromboembolism caused by the mutation site SERPINC1 of the antithrombin III gene: A case report"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5380-9028","authenticated-orcid":false,"given":"Miaoyuan","family":"Lin","sequence":"first","affiliation":[{"name":"Affiliated Hospital of Guangdong Medical University, Zhanjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xishi","family":"Sun","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Guangdong Medical University, Zhanjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Guangdong Medical University, Zhanjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/CNQ.0000000000000158","article-title":"Pathogenesis and epidemiology of venous thromboembolic disease.","volume":"40","author":"Patel","year":"2017","journal-title":"Crit Care Nurs Q"},{"key":"R2-20250503","first-page":"982","article-title":"Chinese expert consensus on the diagnosis of thromboembolism (2012 edition).","volume":"33","year":"2012","journal-title":"Chin J Hematol"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3390\/jcm13020362","article-title":"A comprehensive review of risk factors and thrombophilia evaluation in venous thromboembolism.","volume":"13","author":"Dicks","year":"2024","journal-title":"J Clin Med"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3390\/ijms23031821","article-title":"Inherited thrombophilia in the era of direct oral anticoagulants.","volume":"23","author":"Khider","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R5-20250503","first-page":"249","article-title":"Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency.","volume":"111","author":"Luxembourg","year":"2014","journal-title":"Thromb Haemost"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5045\/br.2018.53.1.81","article-title":"Pulmonary embolism presenting with acute abdominal pain in a girl with stable ankle fracture and inherited antithrombin deficiency.","volume":"53","author":"Park","year":"2018","journal-title":"Blood Res"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1160\/TH16-08-0635","article-title":"Thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency.","volume":"117","author":"Alhenc-Gelas","year":"2017","journal-title":"Thromb Haemost"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/rth2.12025","article-title":"Defects of splicing in antithrombin deficiency.","volume":"1","author":"de la Morena-Barrio","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.3324\/haematol.2018.210666","article-title":"Incidence and features of thrombosis in children with inherited antithrombin deficiency.","volume":"104","author":"Morena-Barrio","year":"2019","journal-title":"Haematologica"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12185-016-2142-8","article-title":"Causative genetic mutations for antithrombin deficiency and their clinical background among Japanese patients.","volume":"105","author":"Sekiya","year":"2017","journal-title":"Int J Hematol"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1182\/blood.V94.8.2590.420k40_2590_2594","article-title":"Gene-gene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiency.","volume":"94","author":"van Boven","year":"1999","journal-title":"Blood"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12881-020-01001-5","article-title":"New genetic variant in the SERPINC1 gene: hereditary antithrombin deficiency case report, familial thrombosis and considerations on genetic counseling.","volume":"21","author":"Polyak","year":"2020","journal-title":"BMC Med Genet"},{"key":"R13-20250503","first-page":"127","article-title":"Phenotype and genetic diagnostic process of hereditary embolism.","volume":"18","author":"Ding","year":"2019","journal-title":"J Diagnost Concepts Pract"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2141.2000.02245.x","article-title":"Molecular bases of antithrombin deficiency in French families: identification of seven novel mutations in the antithrombin gene.","volume":"110","author":"Picard","year":"2000","journal-title":"Br J Haematol"},{"key":"R15-20250503","first-page":"141","article-title":"Deficiency of antithrombin III (AT III) - case report and review of the literature.","volume":"40","author":"G\u0103man","year":"2014","journal-title":"Current Health Sci J"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1161\/01.ATV.14.12.1958","article-title":"Three novel mutations of antithrombin inducing high-molecular-mass compounds.","volume":"14","author":"Emmerich","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.thromres.2015.04.012","article-title":"Puzzling questions on antithrombin: diagnostic limitations and real incidence in venous and arterial thrombosis.","volume":"135","author":"Corral","year":"2015","journal-title":"Thromb Res"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/17474086.2019.1611424","article-title":"Management of antithrombin deficiency: an update for clinicians.","volume":"12","author":"Bravo-P\u00e9rez","year":"2019","journal-title":"Expert Rev Hematol"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.2169\/internalmedicine.55.7314","article-title":"Edoxaban was effective for the treatment of deep vein thrombosis and pulmonary thromboembolism in a cancer patient with antithrombin III deficiency.","volume":"55","author":"Kawano","year":"2016","journal-title":"Internal Med (Tokyo, Japan)"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2169\/internalmedicine.0483-17","article-title":"Efficacy of oral factor Xa inhibitor for venous thromboembolism in a patient with antithrombin deficiency.","volume":"57","author":"Minami","year":"2018","journal-title":"Internal Med (Tokyo, Japan)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:11:47Z","timestamp":1746317507000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":20,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000039175","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,8,2]]}}}